These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 4260803)

  • 1. Rates of recovery of irreversibly inhibited monoamine oxidases: a measure of enzyme protein turnover.
    Planz G; Quiring K; Palm D
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 273(1):27-42. PubMed ID: 4260803
    [No Abstract]   [Full Text] [Related]  

  • 2. Turnover rates of monoamine oxidases: recovery of the irreversibly inhibited enzyme activity and the influence of isoproterenol.
    Planz G; Quiring K; Palm D
    Life Sci I; 1972 Feb; 11(3):147-60. PubMed ID: 4653196
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of drugs on human blood platelet and plasma amine oxidase activity in vitro and in vivo.
    Robinson DS; Lovenberg W; Keiser H; Sjoerdsma A
    Biochem Pharmacol; 1968 Jan; 17(1):109-19. PubMed ID: 4384242
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of substrate in the inhibition of rat liver and brain monoamine oxidase.
    Fuller RW
    Arch Int Pharmacodyn Ther; 1968 Jul; 174(1):32-7. PubMed ID: 4386711
    [No Abstract]   [Full Text] [Related]  

  • 5. The labeling in vivo of monoamine oxidase by 14 C-pargyline: a tool for studying the synthesis of the enzyme.
    Erwin VG; Deitrich RA
    Mol Pharmacol; 1971 Mar; 7(2):219-28. PubMed ID: 5125856
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple forms of monoamine oxidase. Comparison of in vitro and in vivo inhibition patterns.
    Collins GG; Youdim MB; Sandler M
    Biochem Pharmacol; 1972 Jul; 21(14):1995-8. PubMed ID: 4405452
    [No Abstract]   [Full Text] [Related]  

  • 7. N-substituted cyclopropylamines as monoamine oxidase inhibitors. Structure-activity relationships. Dopa potentiation in mice and in vitro inhibition of kynuramine oxidation.
    Mills J; Kattau R; Slater IH; Fuller RW
    J Med Chem; 1968 Jan; 11(1):95-7. PubMed ID: 4384132
    [No Abstract]   [Full Text] [Related]  

  • 8. Irreversible inhibition of monoamine oxidase.
    Planz G; Quiring K; Palm D
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):424-5. PubMed ID: 4253849
    [No Abstract]   [Full Text] [Related]  

  • 9. Selective inhibition of monoamine oxidase in rat brain mitochondria.
    Fuller RW; Warren BJ; Molloy BB
    Biochem Pharmacol; 1970 Nov; 19(11):2934-6. PubMed ID: 5512701
    [No Abstract]   [Full Text] [Related]  

  • 10. [New data on monoamine oxidase inhibitors].
    Gorkin VZ
    Vestn Akad Med Nauk SSSR; 1971; 26(11):23-8. PubMed ID: 4942003
    [No Abstract]   [Full Text] [Related]  

  • 11. Interaction of D-cycloserine with the action of some monoamine oxidase inhibitors.
    Vítek V; Rysánek K
    Biochem Pharmacol; 1965 Oct; 14(10):1417-24. PubMed ID: 4379549
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of monoamine oxidase inhibitors on qualitative alterations in enzymatic properties of mitochondrial monoamine oxidases.
    Abdel Samed MH; Akopyan ZI; Veryovkina IV; Kulygina AA; Gorkin VZ
    Biochem Pharmacol; 1971 Oct; 20(10):2571-7. PubMed ID: 5114498
    [No Abstract]   [Full Text] [Related]  

  • 13. Monoamine oxidase inhibitors.
    Ho BT
    J Pharm Sci; 1972 Jun; 61(6):821-37. PubMed ID: 4558257
    [No Abstract]   [Full Text] [Related]  

  • 14. Early effects of monoamine oxidase inhibitors on dopamine metabolism and monoamine oxidase activity in the neostriatum of the rat.
    Javoy F; Youdim MB; Agid Y; Glowinski J
    J Neural Transm; 1973; 34(4):279-89. PubMed ID: 4149516
    [No Abstract]   [Full Text] [Related]  

  • 15. [Excitormotor effects of tryptamine, in presence of IMAO, in mice pretreated with enzymatic inducers].
    Denys A; Levy J; Michel-Ber E
    Therapie; 1969; 24(5):907-22. PubMed ID: 4391432
    [No Abstract]   [Full Text] [Related]  

  • 16. Another look at the monoamine oxidases and the monoamine oxidase inhibitor drugs.
    Neff NH; Yang HY
    Life Sci; 1974 Jun; 14(11):2061-74. PubMed ID: 4603266
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular turnover numbers of different forms of mitochondrial monoamine oxidase in rat.
    Egashira T; Ekstedt B; Kinemuchi H; Wiberg A; Oreland L
    Med Biol; 1976 Aug; 54(4):272-7. PubMed ID: 957813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of age on the recovery of cardiac monoamine oxidase after irreversible inhibition.
    Horita A
    Biochem Pharmacol; 1968 Oct; 17(10):2091-6. PubMed ID: 5696878
    [No Abstract]   [Full Text] [Related]  

  • 19. Selective brain monoamine oxidase inhibition resulting from an interaction between reversible and irreversible inhibitors.
    Horita A
    Int J Neuropharmacol; 1965 Nov; 4(6):337-42. PubMed ID: 4379937
    [No Abstract]   [Full Text] [Related]  

  • 20. The binding of [3H] pargyline to rat liver mitochondrial monoamine oxidase.
    Parkinson D; Callingham BA
    J Pharm Pharmacol; 1980 Jan; 32(1):49-54. PubMed ID: 6102127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.